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Summary Medicinal leech therapy is an ancient craft that dates back to ancient Egypt
and the beginnings of civilisation. The popularity of Hirudo Medicinalis has varied
throughout history, reaching such a peak in Europe in the early 19th century that
supplies were exhausted. During the latter half of the 19th century, their use fell out of
favour, as they did not fit in with the emerging concepts of modern medicine. Leeches
have enjoyed a renaissance in the world of reconstructive microsurgery during recent
years, and their first reported use in alleviating venous engorgement following flap
surgery was reported in this journal [M Derganc, F Zdravic, Venous congestion of flaps
treated by application of leeches, Br J Plast Surg 13 (1960) 187] [1].
Contemporary plastic and reconstructive surgeons in units throughout the United
Kingdom and Ireland continue to use leeches to aid salvage of failing flaps. We carried
out a survey of all 62 plastic surgery units in the United Kingdom and the Republic of
Ireland to assess the current extent of use, and to investigate current practice.
We have shown that the majority of plastic surgery units in the UK and Ireland use
leeches post-operatively and that the average number of patients requiring leech
therapy was 10 cases per unit per year. Almost all units use antibiotic prophylaxis, but
the type of antibiotic and combination used is variable.
We outline current practice and suggest a protocol for the use of leeches. Whilst the
use of leeches is widespread, the plastic surgery community has progressed little in
defining indications for their use or in achieving an accepted protocol for their
application in units throughout the UK and Ireland.
Q 2004 Published by Elsevier Ltd on behalf of The British Association of Plastic
Surgeons.
The first recorded use of the medicinal leech dates
back to ancient Egypt, with images of the leech
adorning the walls in a sepulchre of the 18th
dynasty pharaohs (1567–1308 BC). Galen (130–201
AD), the physician to Marcus Aurelius, commonly
used leeches for blood letting, and through the
development of his humoral concept of disease
made leech therapy widespread. The belief was
that removal of the patient’s blood would correct
the humoral imbalance and restore good health.
In France, under the influence of Franc¸ois-
Joseph-Victor Broussais (1772–1832), surgeon in
Naploeon’s Grande Arme´e, the use of leeches
reached its zenith. Leeches were so in demand
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that supplies throughout Europe and the United
States of America were almost exhausted. Govern-
ment initiatives to build leech farms had to be
employed to meet demand, and the trafficking of
leeches throughout the world reached an all time
high. By the end of the 19th century, the leech had
lost its popularity as their therapeutic use did not fit
in with the concepts and development of modern
physiology, pathology and microbiology.
Haycraft2 discovered a pure anti-coagulating
preparation contained in the saliva of the leech in
1884 which he named ‘Hirudine’ after the Latin
word ‘Hirudo’, and bought the possible uses of
leech therapy back into mainstream medical
literature.
In 1955, Markwardt3 isolated and accurately
characterised Hirudin from leech pharyngeal
glands, and in 1986 this potent anticoagulant was
first produced in quantity by genetic engineering.4
In addition to Hirudin, the leech also secretes
hyaluronidase, which allows the anticoagulant to
spread throughout the wound, and antihistamines,
which vasodilate and contribute to prolongation of
bleeding following a bite.
The medicinal leech has been used by recon-
structive surgeons in recent years to aid salvage of
compromised microvascular free-tissue transfers,5,6
replanted digits,7 ears,8 lips9,10 and nasal tips.11
Peer-reviewed evidence suggests that the survival
of compromised, venous-congested tissues are
improved by early application of a leech.12 –14
Although we know from our experiences in plastic
surgery units throughout the United Kingdom and
Ireland that leeches are used post-operatively in
certain cases, no quantitative study on this subject
has been previously published. In addition to asses-
sing the current extent of use of Hirudo Medicinalis,
we also assess current practice, and make rec-
ommendations for future improvements in protocols.
Method
A telephone survey of all 62 plastic surgery units in
the United Kingdom and the Republic of Ireland was
conducted in November 2002. The names,
addresses and phone numbers were obtained from
the British Association of Plastic Surgeons Website
(www.baps.co.uk). Information was obtained from
a senior member of nursing staff, who had first hand
experience of the use of leeches on the unit.
1. Are leeches used post-operatively by the plastic
surgeons in your unit?
2. How many times per year on average are leeches
used?
3. Do you use antibiotics routinely post-operatively
when leeches are applied?
4. Do you disinfect sites prior to leech application?
5. How frequently are the leeches monitored?
6. Do you routinely counsel patients?
7. Had any patients refuse treatment with leeches?
8. Were there written protocols for the use of
leeches?
9. Do you keep leeches in the hospital overnight?
Results
Accurate information was gained from 50 (81%) of
the 62 units. Of these, 40 (80%) had used leeches
post-operatively in the salvage of compromised
free flaps or digital replants within the last 5 years.
Fifteen units used leeches 1–5 times per year, 10
units used leeches 6–10 times per year, 12 units
used leeches 11–15 times per year and three units
used leeches more than 16 times per year (see
Fig. 1). The average number of patients requiring
leech treatment was 10 cases per unit using
leeches per year. Thirty seven units used
prophylactic antibiotics routinely during leech
application, with augmentin, metronidazole,
benzyl penicillin, ciprofloxacin and flucloxacillin
all being used (see Fig. 2).
The site of application was disinfected by 31
units (77.5%). Of these, 13 (42%) used sterile water,
12 units (39%) used saline, three units (10%) used
alcohol, one unit (3%) used heparinised saline, one
unit (3%) used warm saline and one unit (3%) used
warm water. Eleven of the 40 units (27.5%)
routinely had a nurse stay with the patient for the
entire duration of ‘leech therapy’. In the remainder
of units, nurses observed at 5–10 min intervals, and
plastic surgeons observed patients when on the
ward. Most units counted leeches on the wound to
avoid losing leeches in the dressings.
Patients were routinely counselled in 21 (52.5%)
of the plastic surgery units, patient information
leaflets were available in four units (10%), and the
services of a clinical psychologist were available in
five units (12.5%). Four units (10%) reported patient
refusals in the last 5 years. Written protocols
concerning the use of leeches were available in 35
units (85%) and 28 units (68%) routinely kept leeches
in the hospital pharmacy overnight.
Discussion
Our study shows that the majority of plastic surgery
units in the United Kingdom and Ireland use Hirudo
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Medicinalis to improve drainage from venously
congested tissue post-operatively. Although pro-
phylactic antibiotics were used by almost all units
questioned, there was no agreement upon the
appropriate antibiotic regimen. Six different anti-
biotics were used, either individually or in
combination.
It has previously been shown that the use of
prophylactic antibiotics with Hirudo therapy is not
ubiquitous,15 and when employed, a range of
antibiotics is used. Infection is possibly the most
worrisome complication of leech application and
generally presents as cellulitis or a local abscess.
The exact incidence of leech-associated infection is
difficult to assess, with incidences ranging from 2.4
to 20% being reported in the literature16,17 ranging
from cellulitis to extensive tissue loss and septi-
caemia.18,19 Extensive studies have been carried
out on the surface and mouth flora of leeches20
which show Aeromonas to be prominent in the
resident flora. Since 1976 three Aeromonas genos-
pecies (Aeromonas hydrophila, Aeromonas sobria
and Aeromonas caviae) have been subdivided into
14 monospecies.21 Infections due to Aeromonas
hydrophila are a recognised complication of leech
application, first described in this journal in 1983.22
Apart from Aeromonas hydrophila, pathogens caus-
ing wound infection following Hirudo therapy that
have been reported in the literature include;
Serratia marcescens,23 Aeromonas sobria24 and
Vibrio fluvialis.25
The single report of Vibrio fluvialis associated
infection may well have been misnamed, as the
API20E method was used for identification pur-
poses. The microbe was almost certainly an Aero-
monad.26 In view of the frequency of human
infections following leech treatments, it would
seem logical to give antibiotics prophylactically.
The occurrence of b-lactamases rules out the use of
first generation cephalosporins and penicillins27,28
and the occasional finding of extended b-lacta-
mases mitigates against the use of synthetic or
semi-synthetic cephalosporins or even penems.
Resistance to septrin and tetracyclines has also
been reported. Our recommendation would be to
use a quinolone (for example ciprofloxacin) with
perhaps an aminoglycoside, as resistance to these
groups has not been cited.
Persistent and prolonged bleeding after the
removal of the leech has long been considered a
complication. In 1819 Anthony White reported that
a 2-year-old girl had died with the loss of blood
induced by a single leech.29 Similar deaths were
described throughout the century. The bleeding,
however, in the vast majority of cases can be well
controlled with direct pressure and topical throm-
bin. It is sensible to keep a daily check on the
haemoglobin during leech therapy, particularly in
young children.
Anaphylaxis and local allergic reactions to
salivary secretory products have been described,30
and excessive scarring has been associated with
leeching.15 The leech’s propensity to migrate after
attachment has caused various problems. Upper
airway obstruction has been described following
leech migration to the hypopharynx and subsequent
engorgement with blood, and haemoptysis has been
reported following leech migration to the
bronchus.31
Early in the 19th century, certain physicians
caused leeches to disgorge themselves by applying
Figure 1 Number of cases requiring Hirudo Therapy per year.
Figure 2 Antibiotic prophylaxis used by plastic surgery
units during Hirudo Therapy.
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salt to their mouths, and in this manner leeches
were used as many as 50 times.24 It is important to
remember that leeches should never be reused as
they have been known to vomit ingested blood if
mishandled, and in theory may have the potential
to transmit infections such as hepatitis and HIV.32
The majority of units disinfected the sites, but
there was no agreement on the appropriate agent
to use. The majority used saline or sterile water,
with three units using alcohol.
Disinfection with alcohol is not to be rec-
ommended as either alcohol or hypertonic saline
may cause the leech to regurgitate blood and
possibly infect the site with its own bacterial
flora. As early as 1804, Wilkinson postulated that
‘the area to which leeches were to be applied
should be washed with soap and water, rinsed
thoroughly, and, when appropriate, shaved very
close to the skin: ‘I have found the sharp points of
the incised hairs so greatly to annoy them as to
prevent their fixing’.33 In the past, if attachment
proved difficult, leeches could be encouraged to
bite by rubbing the target area with sugary water,
milk, or most effectively of all a small quantity of
fresh blood.34 Some physicians found that submer-
ging leeches in diluted wine or very briefly in warm
full strength porter, caused leeches to bite more
vigorously.35 Anecdotal reports indicate that pla-
cing leeches in a smoke filled room impeded leech
attachment.29 It has been recently suggested36 that
submersion of the tissue in water improves leech
attachment. This technique could prove valuable in
situations involving extremities, but is otherwise
somewhat limited.
Staff in approximately half the units routinely
counselled patients on the benefits and psychologi-
cal aspects of leech therapy, and the services of a
clinical psychologist were available in some units.
Patient information leaflets were not often avail-
able. All units got informed consent from the
patient before leech therapy was instituted, and
it was well received by virtually all, with only a
small number of units reporting patient noncom-
pliance within the last 5 years. This may be due to
the fact that patients saw the leeches as a ‘last
resort’ in salvaging the compromised tissue. Writ-
ten protocols were available in the majority of
units, and over half routinely kept leeches in the
hospital pharmacy overnight.
For a unit to use leeches, the hospital pharmacy
must buy a storage tank and medium in addition to
the leeches. In 1981, an American biologist, Roy
Sawyer, abandoned his academic career to found
Biopharm Ltd, a company in Swansea, Wales,
devoted to breeding and farming leeches and
developing new drugs for clinical application.
Biopharm Ltd estimated that they supply approxi-
mately 25 000 leeches to the United Kingdom and
Ireland each year and 60 000 to the United States of
America.
Suggested protocol for the use of leeches
We suggest a protocol based on our review of
relevant literature, the information pack from
Biopharm UK and research into various hospital
guidelines.
General considerations
Leeches should be kept in a cool environment to
enhance performance and in warm weather, a cold
jacket should be placed around the jar approxi-
mately half an hour before application.
Preparation of the site
Clean the patient’s skin thoroughly with warmed
heparinised saline to enhance vasodilation, pro-
mote ongoing bleeding and remove any ointment,
alcohol or iodine from the skin that could in theory
impede attachment. Dampen a square of gauze
with sterile water and cut a 1 cm hole in the middle.
Place the gauze in close contact with the cleansed
area, with the hole over the required attachment
site. This will form a barrier to help prevent the
leech from migrating. The area can be then pricked
with a hypodermic needle to encourage the animal
to attach to the specified area as the process of
encouraging the leech to feed can be taxing.
Handling and application
Pick up the leech with care, using either
polythene gloves or plain unserrated forceps and
steer the leech’s head to the hole in the gauze.
Once attached, the leech will remain safely in place
until fully distended (30–60 min). It is important to
be vigilant and check the wound site often to ensure
that the leech has not migrated or detached
prematurely which may result in aforementioned
complications. Once fully engorged the leech will
detach. The leech should not be forcibly removed.
NB To detach an errant leech rapidly, sprinkle its
head with common salt. They should never be
forcibly removed from a surface.
Prophylactic antibiotics37
A prophylactic regimen of a quinolone (for
example ciprofloxacin) with an aminoglycoside
should be used for the entire duration of leech
application. Patients treated with leeches and
discharged with eschars or open wounds should
continue oral antibiotic therapy until wound
closure.
Daily investigations
Haemoglobin should be checked at least daily for
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the duration of leech therapy to help monitor blood
loss particularly in young children.
After-care of wounds
The therapeutic effect of leech application is
gained almost entirely in this period, and depends
greatly on the care given to the bite wounds. Each
bite must be encouraged to bleed by gently
removing any locally forming clot at regular
intervals.
Re-use of leeches
Leeches should not be re-used-fresh and used
leeches must be kept completely separate and
labelled clearly.
Disposal of leeches
Used leeches are treated as clinical waste; on no
account should used leeches be returned to
pharmacy. They must not be flushed down a toilet
or sluice. Leeches should be placed in a small screw
capped jar with about 20 ml of 8% ethanol and
clearly labelled with the patients name. After 3 min
50 ml of 70% methylated spirit should be added and
lid replaced securely. The jar should be put in a
sharps container and send for incineration.
We have shown that whilst the use of leeches is
widespread we have progressed little in defining
indications for their use or in achieving an accepted
protocol for their application in plastic surgery
units in the UK.
Whilst traditionally leeches have been used for
attempted salvage of relatively small volumes of
tissue, for example finger or ear amputations or
sub-total amputations, most surgeons seem to
develop their own indications with experience.
The ancient craft of leech application still has a
place in contemporary reconstructive surgery and
remain a useful part of the armamentarium for the
plastic surgeon.
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